www.stagezerolifesciences.com Open in urlscan Pro
199.34.228.77  Public Scan

Submitted URL: http://stagezerolifesciences.com/
Effective URL: https://www.stagezerolifesciences.com/
Submission: On September 22 via api from US — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

 * About
 * Cancer Testing
 * COVID-19 Testing
 * Physicians
 * INVESTORS
 * Contact

Cart (0)
 * Our Science >
    * The Sentinel Principle

 * Publications
 * Board of Directors
 * Partners
 * Scientific Advisory Board

 * Aristotle-Test

 * COVID-19 Travel Solutions
 * Return-to-Work
 * Return-to-Learn
 * COVID-19-ONSITE-TESTING
 * TESTS >
    * Covid-19-PCR
    * Covid-19-Antibody
    * Respiratory Panel + COVID-19

 * Frequently Asked Questions

 * Establish an Account
 * Order Supplies
 * Copia Login

 * Investor Relations
 * Press Releases
 * Investor FAQs
 * Events
 * In the News

 * Customer Support
 * Corporate HQ
 * Careers
 * Bill Payment

Helping to Improve Cancer Outcomes
at Every Stage
Providing solutions to Help Improve Cancer Outcomes Through Early Detection,
Prevention, and Intervention





OUR STORY

StageZero Life Sciences, Ltd. (TSX:SZLS) (OTCQB:SZLSF) is a global, vertically
integrated healthcare company dedicated to improving outcomes for cancer and
other chronic diseases through early detection and intervention. We deliver this
through a comprehensive, physician supervised telehealth program which uses
advanced diagnostics to help detect cancer and chronic disease in the earliest
stages when they are most treatable.


PIONEERS IN LIQUID BIOPSY

As early pioneers in liquid biopsies, we developed one of the first blood-based
biomarker tests for the early identification of Colorectal Cancer. ColonSentry®
 uses our proprietary Sentinel Principle® technology which is based on the
scientific observation that circulating blood reflects, in a detectable way,
what is occurring throughout the body. StageZero's Sentinel Principle®
technology has been validated in more than 9,000 patients and used by more than
100,000 patients in North America. The Company's next-generation test,
Aristotle™, is the first mRNA-based, multi-cancer panel for simultaneously
screening for multiple cancers from a single sample of blood with high
sensitivity and specificity for each cancer. 


OUR LABORATORY

Our laboratory in Richmond, VA is registered and certified according to the
Clinical Laboratory Improvement Amendment (CLIA) for high complexity laboratory
testing through the Centers of Medicare and Medicaid Services (CMS). In
addition, the lab is accredited through the U.S. College of American
Pathologists (CAP). These certifications demonstrate our highest commitment to
excellence in laboratory test processing and our passion for patient care. 



OUR TESTS

The Company's next-generation test, Aristotle®,  is a multi-cancer test panel
that uses mRNA technology to simultaneously detect multiple cancer signatures
from a single sample of blood. In addition to Aristotle®, we provide individual
testing for Colorectal Cancer risk (ColonSentry®),  and Prostate Cancer risk 
(The Prostate Health Index). In addition, the Company is also leveraging its
specialty in polymerase chain reaction (PCR) testing to provide COVID-19 PCR
testing (swab and saliva) and Antibody Testing (blood analysis).



OUR CARE

Our wholly owned subsidiary, Care Oncology, Inc. provides a unique telehealth
platform to deliver two revolutionary programs. 
U.S. Physician services are delivered by Care Oncology Physicians, P.C. 

U.K Physician services are delivered by The Care Oncology Clinic in London.

The COC Protocol
The COC Protocol is a telehealth clinical service that offers professionally
guided adjunctive care for patients living with cancer. The COC Protocol is
designed to work primarily by restricting the overall ability of cancer cells to
take up and use (i.e., ‘metabolize’) energy. By targeting the adapted metabolic
mechanisms which are common to most cancers, it makes it more difficult overall
for cancer cells to survive, grow, and spread in the body. 

Learn More

AVRT
AVRT specializes in identifying and managing the early warning signs of
cancer. Created by the physicians and scientists who developed the
ground-breaking COC Protocol, AVRT uses a similar approach by identifying and
targeting the inflammatory and metabolic pathways that may increase the risk of
developing cancer and chronic disease, and intervenes early to influence the
metabolic pathways that could lead to disease progression.



Learn More


Aristotle™ and ColonSentry were developed, and their performance characteristics
determined by Stage Zero Life Sciences, Inc.; they have not been cleared or
approved by the US Food and Drug Administration. The Prostate Health Index (phi)
is an FDA approved blood test that can help differentiate prostate cancer from
benign conditions in men with elevated PSA. The Aristotle, ColonSentry, and
Prostate Health Index tests must be ordered by and used only in consultation
with a healthcare provider. 


StageZero Life Sciences. Ltd.
30-70 East Beaver Creek Road
Richmond Hill, Ontario L4B 3B2



StageZero Life Sciences, Inc.
8751 Park Central Drive, Suite 200
Richmond, VA 23227
TEL: 855.420.7140 
Contact Information




Notice of Privacy Practices | Terms & Conditions | Privacy Statement & Policy
| Licensing & Accreditation
 * About
    * Our Science >
       * The Sentinel Principle
   
    * Publications
    * Board of Directors
    * Partners
    * Scientific Advisory Board

 * Cancer Testing
    * Aristotle-Test

 * COVID-19 Testing
    * COVID-19 Travel Solutions
    * Return-to-Work
    * Return-to-Learn
    * COVID-19-ONSITE-TESTING
    * TESTS >
       * Covid-19-PCR
       * Covid-19-Antibody
       * Respiratory Panel + COVID-19
   
    * Frequently Asked Questions

 * Physicians
    * Establish an Account
    * Order Supplies
    * Copia Login

 * INVESTORS
    * Investor Relations
    * Press Releases
    * Investor FAQs
    * Events
    * In the News

 * Contact
    * Customer Support
    * Corporate HQ
    * Careers
    * Bill Payment

   


 * Empty Cart

Subtotal: $0.00
Checkout